Gyre Therapeutics Inc. (GYRE) — Cash Flow-to-Debt Ratio
Gyre Therapeutics Inc. (GYRE) has a Cash Flow-to-Debt Ratio of 0.21x as of September 2025, meaning its operating cash flow of $4.68 Million could theoretically repay 0% of its total liabilities ($21.97 Million) in one year. See GYRE cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Gyre Therapeutics Inc. Cash Flow-to-Debt Ratio (2004–2024)
Historical debt coverage capacity for Gyre Therapeutics Inc. across 21 annual periods. Also explore Gyre Therapeutics Inc. (GYRE) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Gyre Therapeutics Inc. (2004–2024)
Year-by-year debt coverage analysis for Gyre Therapeutics Inc.. For market capitalisation and broader financial context, see Gyre Therapeutics Inc. market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.13x | $-3.64 Million | $27.00 Million | ▼ -153.4% |
| 2023 | 0.25x | $25.89 Million | $102.59 Million | ▼ -70.4% |
| 2022 | 0.85x | $10.68 Million | $12.54 Million | ▲ +114.8% |
| 2021 | -5.75x | $-83.75 Million | $14.57 Million | ▼ -96.0% |
| 2020 | -2.93x | $-55.05 Million | $18.78 Million | ▼ -103.1% |
| 2019 | -1.44x | $-43.61 Million | $30.22 Million | ▲ +74.9% |
| 2018 | -5.74x | $-28.55 Million | $4.97 Million | ▼ -151.5% |
| 2017 | -2.28x | $-19.94 Million | $8.74 Million | ▼ -172.0% |
| 2016 | -0.84x | $-18.47 Million | $22.02 Million | ▼ -67.2% |
| 2015 | -0.50x | $-19.12 Million | $38.10 Million | ▲ +95.8% |
| 2014 | -11.83x | $-34.48 Million | $2.91 Million | ▼ -228.2% |
| 2013 | -3.61x | $-40.61 Million | $11.26 Million | ▲ +23.3% |
| 2012 | -4.70x | $-64.24 Million | $13.66 Million | ▼ -370.8% |
| 2011 | -1.00x | $-83.72 Million | $83.84 Million | ▼ -223.4% |
| 2010 | 0.81x | $138.30 Million | $170.94 Million | ▲ +934.6% |
| 2009 | -0.10x | $-24.27 Million | $250.39 Million | ▲ +85.9% |
| 2008 | -0.69x | $-28.26 Million | $41.18 Million | ▼ -230.9% |
| 2007 | 0.52x | $24.84 Million | $47.38 Million | ▲ +186.7% |
| 2006 | -0.60x | $-9.89 Million | $16.37 Million | ▼ -338.6% |
| 2005 | -0.14x | $-26.25 Million | $190.48 Million | ▲ +0.3% |
| 2004 | -0.14x | $-25.04 Million | $181.17 Million | — |